End-of-day quote
Shanghai S.E.
23:00:00 14/07/2024 BST
|
5-day change
|
1st Jan Change
|
11.23
CNY
|
-3.93%
|
|
-0.62%
|
-60.54%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,660
|
3,783
|
3,506
|
1,384
|
-
|
Enterprise Value (EV)
1 |
6,660
|
3,783
|
3,506
|
1,384
|
1,384
|
P/E ratio
|
68.8
x
|
91.5
x
|
-49.1
x
|
4.21
x
|
3.35
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
16,977,586
x
|
-
|
-
|
-
|
-
|
EV / Revenue
|
16,977,586
x
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
58,847,022
x
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
4.56
x
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
123,200
|
123,200
|
123,200
|
123,200
|
-
|
Reference price
2 |
54.06
|
30.71
|
28.46
|
11.23
|
11.23
|
Announcement Date
|
25/02/22
|
19/04/23
|
15/04/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
|
-
|
392.3
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
113.2
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
83.97
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
21.41%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
84
|
-
|
-
|
-
|
-
|
Net income
1 |
155
|
82.46
|
41.54
|
-70.99
|
328.8
|
413
|
Net margin
|
-
|
21.02%
|
-
|
-
|
-
|
-
|
EPS
2 |
1.679
|
0.7857
|
0.3357
|
-0.5800
|
2.670
|
3.350
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/07/21
|
25/02/22
|
19/04/23
|
15/04/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
10.9%
|
-
|
-5.02%
|
17.7%
|
19.1%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
11.90
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
0.8400
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/07/21
|
25/02/22
|
19/04/23
|
15/04/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -60.54% | 191M | | +7.40% | 101B | | +7.76% | 42.18B | | -14.37% | 32.26B | | +81.37% | 29.79B | | -12.27% | 16.06B | | +2.33% | 14.45B | | -8.56% | 12.01B | | +182.74% | 10.71B | | +2.25% | 8.89B |
Biopharmaceuticals
|